Michael Gendreau博士将在2025年10月7日的疼痛治疗峰会上介绍 Dogwood治疗师Halnemoron 慢性疼痛研究。 Dr. Michael Gendreau will present Dogwood Therapeutics' Halneuron® chronic pain research at the Pain Therapeutics Summit on October 7, 2025.

Dogwood治疗学首席医官Michael Gendreau博士将在第19届年度疼痛治疗峰会上概述该公司的Hal中中子疼痛研究计划,重点强调目前正在努力开发新的慢性疼痛治疗方法。 Dr. Michael Gendreau, Chief Medical Officer of Dogwood Therapeutics, will present an overview of the company’s Halneuron® pain research program at the 19th Annual Pain Therapeutics Summit, highlighting ongoing efforts to develop new treatments for chronic pain. 该专题介绍定于2025年10月7日进行,重点将放在该方案的科学方法和潜在的临床应用上。 The presentation is scheduled for October 7, 2025, and will focus on the program’s scientific approach and potential clinical applications.